Targeted Precision, Complex Promise

Thursday, April 2, 2026Kathy VuksanajView original

Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept into one of oncology’s most dynamic therapeutic classes. By fusing the targeting specificity of monoclonal antibodies with the cell-killing power of highly […]

The post Targeted Precision, Complex Promise appeared first on GEN - Genetic Engineering and Biotechnology News.